MET and neoplasm: Subsequently, this causes upregulation of proangiogenic factors, such as VEGF that stimulates angiogenesis, cMET upregulation that increases tumor invasiveness and epithelial-to-mesenchymal transition, and stromal cell-derived factor-1 upregulation that recruits proangiogenic bone marrow-derived cells.